Cargando…

Predicting miRNA targets for hepatocellular carcinoma with an integrated method

BACKGROUND: MicroRNAs (miRNAs) were aberrantly regulated in cancers, showing their roles as novel classes of oncogenes and tumor suppressors. Hence, an integrated method was introduced in this study to explore miRNA targets for hepatocellular carcinoma (HCC). METHODS: The Borda count election algori...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yi-Hua, Wen, Tian-Fu, Xiao, De-Shuang, Dai, Ling-Bo, Song, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798414/
https://www.ncbi.nlm.nih.gov/pubmed/35117522
http://dx.doi.org/10.21037/tcr.2020.02.46
_version_ 1784641800307212288
author Shi, Yi-Hua
Wen, Tian-Fu
Xiao, De-Shuang
Dai, Ling-Bo
Song, Jun
author_facet Shi, Yi-Hua
Wen, Tian-Fu
Xiao, De-Shuang
Dai, Ling-Bo
Song, Jun
author_sort Shi, Yi-Hua
collection PubMed
description BACKGROUND: MicroRNAs (miRNAs) were aberrantly regulated in cancers, showing their roles as novel classes of oncogenes and tumor suppressors. Hence, an integrated method was introduced in this study to explore miRNA targets for hepatocellular carcinoma (HCC). METHODS: The Borda count election algorithm was applied to combine a correlation method (Pearson’s correlation coefficient, PCC), a causal inference method (IDA), and a regression method (Lasso) to generate an integrated method. Subsequently, to confirm the performance of the integrated method, the predicted miRNA targets results were compared with the confirmed database. Finally, pathway enrichment analysis was applied to evaluate the target genes in the top 1,000 miRNA-messenger RNA (mRNA) interactions. RESULTS: The method was confirmed to be an approach to predict miRNA targets. Moreover, 50 highly confident miRNA-mRNA interactions were obtained, including 6 miRNA targets with predicted times ≥10 (for instance, MEG3). The 860 target genes of the top 1,000 miRNA-mRNA interactions were enriched in 26 pathways, of which complement and coagulation cascades were most significant. CONCLUSIONS: The results might supply great insights for revealing the pathological mechanism underlying HCC and explore potential biomarkers for the diagnosis and treatment of this tumor. However, these biomarkers have not been confirmed, and the related validations should be performed in future studies.
format Online
Article
Text
id pubmed-8798414
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87984142022-02-02 Predicting miRNA targets for hepatocellular carcinoma with an integrated method Shi, Yi-Hua Wen, Tian-Fu Xiao, De-Shuang Dai, Ling-Bo Song, Jun Transl Cancer Res Original Article BACKGROUND: MicroRNAs (miRNAs) were aberrantly regulated in cancers, showing their roles as novel classes of oncogenes and tumor suppressors. Hence, an integrated method was introduced in this study to explore miRNA targets for hepatocellular carcinoma (HCC). METHODS: The Borda count election algorithm was applied to combine a correlation method (Pearson’s correlation coefficient, PCC), a causal inference method (IDA), and a regression method (Lasso) to generate an integrated method. Subsequently, to confirm the performance of the integrated method, the predicted miRNA targets results were compared with the confirmed database. Finally, pathway enrichment analysis was applied to evaluate the target genes in the top 1,000 miRNA-messenger RNA (mRNA) interactions. RESULTS: The method was confirmed to be an approach to predict miRNA targets. Moreover, 50 highly confident miRNA-mRNA interactions were obtained, including 6 miRNA targets with predicted times ≥10 (for instance, MEG3). The 860 target genes of the top 1,000 miRNA-mRNA interactions were enriched in 26 pathways, of which complement and coagulation cascades were most significant. CONCLUSIONS: The results might supply great insights for revealing the pathological mechanism underlying HCC and explore potential biomarkers for the diagnosis and treatment of this tumor. However, these biomarkers have not been confirmed, and the related validations should be performed in future studies. AME Publishing Company 2020-03 /pmc/articles/PMC8798414/ /pubmed/35117522 http://dx.doi.org/10.21037/tcr.2020.02.46 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Shi, Yi-Hua
Wen, Tian-Fu
Xiao, De-Shuang
Dai, Ling-Bo
Song, Jun
Predicting miRNA targets for hepatocellular carcinoma with an integrated method
title Predicting miRNA targets for hepatocellular carcinoma with an integrated method
title_full Predicting miRNA targets for hepatocellular carcinoma with an integrated method
title_fullStr Predicting miRNA targets for hepatocellular carcinoma with an integrated method
title_full_unstemmed Predicting miRNA targets for hepatocellular carcinoma with an integrated method
title_short Predicting miRNA targets for hepatocellular carcinoma with an integrated method
title_sort predicting mirna targets for hepatocellular carcinoma with an integrated method
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798414/
https://www.ncbi.nlm.nih.gov/pubmed/35117522
http://dx.doi.org/10.21037/tcr.2020.02.46
work_keys_str_mv AT shiyihua predictingmirnatargetsforhepatocellularcarcinomawithanintegratedmethod
AT wentianfu predictingmirnatargetsforhepatocellularcarcinomawithanintegratedmethod
AT xiaodeshuang predictingmirnatargetsforhepatocellularcarcinomawithanintegratedmethod
AT dailingbo predictingmirnatargetsforhepatocellularcarcinomawithanintegratedmethod
AT songjun predictingmirnatargetsforhepatocellularcarcinomawithanintegratedmethod